News
Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...
Week Low Stocks to Buy Right Now. On June 26, Merck & Co., Inc. (NYSE:MRK) announced that the Advisory Committee on Immunization Practices has approved ENFLONSIA for preventing respiratory syncytial ...
Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that ...
The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't ...
Immunizations “are not all good or bad,” says the chair of the overhauled panel.
The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...
Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months.
The CDC’s Advisory Committee on Immunization Practices (ACIP) has blessed Merck’s new respiratory syncytial virus (RSV) shot ...
Although the U.S. CDC’s Advisory Committee for Immunization Practices (ACIP) was scheduled to vote June 25 on recommendations ...
A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend use of a new shot ...
10don MSN
The Centers for Disease Control and Prevention's vaccine advisory committee voted on Thursday to recommend infants receive a ...
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results